Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, August 2004, p. 3141-3146, Vol. 48, No. 8
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.8.3141-3146.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Lack of Evidence that DNA in Antibiotic Preparations Is a Source of Antibiotic Resistance Genes in Bacteria from Animal or Human Sources
Susanna K. P. Lau, Patrick C. Y. Woo, Amanda P. C. To, Alexson T. K. Lau, and Kwok-yung Yuen*
Department of Microbiology, The University of Hong Kong, Queen Mary Hospital, Hong Kong
Received 31 July 2003/
Returned for modification 2 January 2004/
Accepted 5 April 2004

ABSTRACT
Although DNA encoding antibiotic resistance has been discovered
in antibiotic preparations, its significance for the development
of antibiotic resistance in bacteria is unknown. No phylogenetic
evidence was obtained for recent horizontal transfer of antibiotic
resistance genes from antibiotic-producing organisms to bacteria
from human or animal sources.

TEXT
Although the use of antibiotics has been the major weapon in
combating infectious diseases, the rapid development of antibiotic
resistance has resulted in treatment failures and outbreaks
of infections caused by antibiotic-resistant bacteria (
2,
5,
10,
11,
15). Numerous studies have proven that the use of an
antibiotic is closely related to the rate of resistance to that
antibiotic (
3,
4). Traditionally, the role of antibiotics in
antibiotic-induced antimicrobial resistance is to provide selective
pressures to resistant clones. In 1990, Chakrabarty et al. reported
the detection of nucleic acids in various antibiotics and the
capacity of such nucleic acids to transform bacteria to drug
resistance (
1). Subsequently, Webb and Davies demonstrated that
DNA encoding antibiotic resistance genes that are present in
bacteria used in the production of antibiotics can be recovered
in antibiotic preparations (
9). It was proposed that antimicrobial
resistance genes may be coadministered with antibiotics to humans
or animals and taken up by bacteria in the hosts, contributing
to the rapid development of antibiotic resistance. However,
the importance of this second mechanism in the present widespread
antibiotic resistance was unknown. In this study, we examined
by a comprehensive phylogenetic analysis whether recent horizontal
transfer of antibiotic resistance genes from antibiotic-producing
organisms to human or animal bacteria has occurred. The phylogenetic
relationships of the genes among different bacteria were also
studied.
All antibiotic resistance genes that were present in the corresponding antibiotic-producing and non-antibiotic-producing organisms were included in this study (Medline search from 1966 to June 2003 and GenBank search from 1988 to June 2003) (Table 1). Amino acid sequences were used for phylogenetic analysis to minimize the effect of codon usage bias among different bacteria after gene acquisition. All were published sequences downloaded from GenBank (http://www.ncbi.nlm.nih.gov) and were aligned by multiple-sequence alignment with the CLUSTAL W program (8). For phylogenetic tree construction, all sequences found in the corresponding antibiotic-producing organisms and at least 10 sequences from human or animal bacterial isolates closest to those from antibiotic-producing organisms by BLAST search were included. Phylogenetic tree construction was performed with ClustalX version 1.81 (6) and the neighbor-joining method with GrowTree (Genetics Computer Group, Inc., San Diego, Calif.).
A total of 13 antibiotic resistance genes that were present
in both the corresponding antibiotic-producing and non-antibiotic-producing
organisms were found (Table
1). Phylogenetic tree construction
was performed on the first 10 genes. For the last three genes,
fewer than 10 sequences were found in non-antibiotic-producing
organisms and they were analyzed by multiple-sequence alignment
alone.
The erm sequences of the macrolide and lincosamide producers were distant from those of human or clinical bacterial isolates (amino acid identities of less than 40%). Recent horizontal transfer of erm genes from the antibiotic producers to human or animal bacteria was not observed. In contrast, the sequences within the human or animal bacteria were more closely related among themselves and showed evidence of frequent horizontal transfer, even between gram-positive and gram-negative bacteria. In particular, transfer among human gut bacteria was very common. There also appeared to be two clusters of genes that evolved independently, one generally from human or animal bacteria and the other generally from environmental bacteria, including the antibiotic producers (Fig. 1).
The tetracycline resistance ribosomal protection protein of
the tetracycline producer
Streptomyces rimosus was also distantly
related to those of human or clinical bacterial isolates (amino
acid identities of less than 50%), indicating no evidence of
recent horizontal gene transfer from the antibiotic producer
to human or clinical bacteria. In contrast, closely related
genes among human or clinical bacteria were observed. Horizontal
gene transfer appeared to have occurred among distantly related
bacteria and the female genital tract flora and pathogens (Fig.
2).
Phylogenetic studies of the other 11 genes showed patterns similar
to those reported in detail for
erm and tetracycline resistance
ribosomal protection protein. The results of their phylogenetic
analysis are summarized in Table
1. The maximum amino acid identities
of genes among different non-antibiotic-producing bacterial
isolates were close to 100% for most genes, but those between
antibiotic-producing and human or animal bacteria ranged from
<28 to <77%.
From the present study, recent horizontal transfer of antibiotic resistance genes from bacteria that are used for antibiotic production to human or animal bacteria was not observed. Although our results suggest that DNA in antibiotic preparations has not been a very active and widespread mechanism in the dissemination of antibiotic resistance genes, the possibility of its being a minor player cannot be excluded. Nevertheless, our results suggest that DNA decontamination of antibiotic preparations is probably unnecessary. On the other hand, the fact that horizontal transfer was observed among human gastrointestinal tract bacteria, which is in line with our previous findings (7, 12), suggests that this is one of the other possible mechanisms of antibiotic-induced antibiotic resistance (13, 14).

ACKNOWLEDGMENTS
This work was partly supported by the University Development
Fund, University Research Grant Council, and the Committee of
Research and Conference Grants, The University of Hong Kong.

FOOTNOTES
* Corresponding author. Mailing address: Department of Microbiology, The University of Hong Kong, University Pathology Building, Queen Mary Hospital, Hong Kong. Phone: (852) 28554892. Fax: (852) 28551241. E-mail:
hkumicro{at}hkucc.hku.hk.


REFERENCES
1 - Chakrabarty, A. N., S. G. Dastidar, M. Ganguli, and D. Chattopadhyay. 1990. 'DNA' as contaminants in antibiotics and its capacity to transform bacteria to drug resistance. Indian J. Exp. Biol. 28:58-62.[Medline]
2 - Chiu, S. S., P. L. Ho, F. K. Chow, K. Y. Yuen, and Y. L. Lau. 2001. Nasopharyngeal carriage of antimicrobial-resistant Streptococcus pneumoniae among young children attending 79 kindergartens and day care centers in Hong Kong. Antimicrob. Agents Chemother. 45:2765-2770.[Abstract/Free Full Text]
3 - Cristino, J. M. 1999. Correlation between consumption of antimicrobials in humans and development of resistance in bacteria. Int. J. Antimicrob. Agents 12:199-202.[CrossRef][Medline]
4 - Granizo, J. J., L. Aguilar, J. Casal, C. Garcia-Rey, R. Dal-Re, and F. Baquero. 2000. Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997). J. Antimicrob. Chemother. 46:767-773.[Abstract/Free Full Text]
5 - Ho, P. L., K. Y. Yuen, W. C. Yam, S. S. Y. Wong, and W. K. Luk. 1995. Changing patterns of susceptibilities of blood, urinary and respiratory pathogens in Hong Kong. J. Hosp. Infect. 31:305-317.[CrossRef][Medline]
6 - Jeanmougin, F., J. D. Thompson, M. Gouy, D. G. Higgins, and T. J. Gibson. 1998. Multiple sequence alignment with ClustalX. Trends Biochem. Sci. 10:403-405.
7 - Lee, R. A., P. C. Y. Woo, A. P. C. To, S. K. P. Lau, S. S. Y. Wong, and K. Y. Yuen. 2003. Geographical difference of disease association in Streptococcus bovis bacteremia. J. Med. Microbiol. 52:903-908.[Abstract/Free Full Text]
8 - Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.[Abstract/Free Full Text]
9 - Webb, V., and J. Davies. 1993. Antibiotic preparations contain DNA: a source of drug resistance genes? Antimicrob. Agents Chemother. 37:2379-2384.[Abstract/Free Full Text]
10 - Wong, S. S. Y., P. L. Ho, P. C. Y. Woo, and K. Y. Yuen. 1999. Bacteremia caused by staphylococci with inducible vancomycin heteroresistance. Clin. Infect. Dis. 29:760-767.[Medline]
11 - Wong, S. S. Y., T. K. Ng, W. C. Yam, D. N. C. Tsang, P. C. Y. Woo, S. K. S. Fung, and K. Y. Yuen. 2000. Bacteremia due to Staphylococcus aureus with reduced susceptibility to vancomycin. Diagn. Microbiol. Infect. Dis. 36:261-268.[CrossRef][Medline]
12 - Woo, P. C. Y., A. P. C. To, H. Tse, S. K. P. Lau, and K. Y. Yuen. 2003. Clinical and molecular epidemiology of erythromycin resistant beta-hemolytic Lancefield group G streptococci causing bacteremia. J. Clin. Microbiol. 41:5188-5191.[Abstract/Free Full Text]
13 - Woo, P. C. Y., A. P. C. To, S. K. P. Lau, and K. Y. Yuen. 2003. Facilitation of horizontal transfer of antimicrobial resistance by transformation of antibiotic-induced cell-wall-deficient bacteria: a hypothesis. Med. Hypotheses 61:503-508.[CrossRef][Medline]
14 - Woo, P. C. Y., S. S. Y. Wong, P. N. L. Lum, W. T. Hui, and K. Y. Yuen. 2001. Cell-wall-deficient bacteria and culture-negative febrile episodes in bone-marrow-transplant recipients. Lancet 357:675-679.[CrossRef][Medline]
15 - Yuen, K. Y., W. H. Seto, W. T. Hui, and P. Y. Chau. 1990. Multi-resistant Streptococcus pneumoniae in Hong Kong. J. Antimicrob. Chemother. 25:721-723.[Free Full Text]
Antimicrobial Agents and Chemotherapy, August 2004, p. 3141-3146, Vol. 48, No. 8
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.8.3141-3146.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Chee-Sanford, J. C., Mackie, R. I., Koike, S., Krapac, I. G., Lin, Y.-F., Yannarell, A. C., Maxwell, S., Aminov, R. I.
(2009). Fate and Transport of Antibiotic Residues and Antibiotic Resistance Genes following Land Application of Manure Waste. J. Environ. Qual.
38: 1086-1108
[Abstract]
[Full Text]
-
Woegerbauer, M., Lagler, H., Graninger, W., Burgmann, H.
(2005). DNA in Antibiotic Preparations: Absence of Intact Resistance Genes. Antimicrob. Agents Chemother.
49: 2490-2494
[Abstract]
[Full Text]